ITPKC functional polymorphism associated with Kawasaki disease susceptibility and formation of coronary artery aneurysms

Kawasaki disease is a pediatric systemic vasculitis of unknown etiology for which a genetic influence is suspected. We identified a functional SNP (itpkc_3) in the inositol 1,4,5-trisphosphate 3-kinase C (ITPKC) gene on chromosome 19q13.2 that is significantly associated with Kawasaki disease susceptibility and also with an increased risk of coronary artery lesions in both Japanese and US children. Transfection experiments showed that the C allele of itpkc_3 reduces splicing efficiency of the ITPKC mRNA. ITPKC acts as a negative regulator of T-cell activation through the Ca2+/NFAT signaling pathway, and the C allele may contribute to immune hyper-reactivity in Kawasaki disease. This finding provides new insights into the mechanisms of immune activation in Kawasaki disease and emphasizes the importance of activated T cells in the pathogenesis of this vasculitis.

[1]  E. Buratti,et al.  Influence of RNA Secondary Structure on the Pre-mRNA Splicing Process , 2004, Molecular and Cellular Biology.

[2]  Dan R. Littman,et al.  Signal transduction by lymphocyte antigen receptors , 1994, Cell.

[3]  Yusuke Nakamura,et al.  Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis , 2003, Nature Genetics.

[4]  Richard S Lewis,et al.  Calcium signaling mechanisms in T lymphocytes. , 2001, Annual review of immunology.

[5]  Yoshikazu Nakamura,et al.  Revision of diagnostic guidelines for Kawasaki disease (the 5th revised edition) , 2005, Pediatrics international : official journal of the Japan Pediatric Society.

[6]  J. Imboden,et al.  Regulation of inositol 1,4,5-trisphosphate kinase activity after stimulation of human T cell antigen receptor. , 1987, The Journal of clinical investigation.

[7]  S. Koike,et al.  Coronary aneurysms in infants and young children with acute febrile mucocutaneous lymph node syndrome. , 1975, The Journal of pediatrics.

[8]  K Hashino,et al.  Long-term consequences of Kawasaki disease. A 10- to 21-year follow-up study of 594 patients. , 1996, Circulation.

[9]  T. Onodera,et al.  Prediction of non-responsiveness to intravenous high-dose gamma-globulin therapy in patients with Kawasaki disease at onset. , 2000, The Journal of pediatrics.

[10]  J. Cogan,et al.  A novel mechanism of aberrant pre-mRNA splicing in humans. , 1997, Human molecular genetics.

[11]  C. Erneux,et al.  Cloning and expression of a cDNA encoding human inositol 1,4,5-trisphosphate 3-kinase C. , 2000, The Biochemical journal.

[12]  A. Feinberg,et al.  Hot-stop PCR: a simple and general assay for linear quantitation of allele ratios , 2000, Nature Genetics.

[13]  T. Chatila,et al.  Response of refractory Kawasaki disease to pulse steroid and cyclosporin A therapy. , 2001, The Pediatric infectious disease journal.

[14]  W. Ewens,et al.  Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). , 1993, American journal of human genetics.

[15]  S. Kurotobi,et al.  Prediction of non-responsiveness to standard high-dose gamma-globulin therapy in patients with acute Kawasaki disease before starting initial treatment , 2006, European Journal of Pediatrics.

[16]  R. Rowe,et al.  Results from an international survey of Kawasaki disease in 1979-82. , 1989, The Canadian journal of cardiology.

[17]  J. Hampe,et al.  Single base‐pair substitutions in exon–intron junctions of human genes: nature, distribution, and consequences for mRNA splicing , 2007, Human mutation.

[18]  Michael J. Berridge,et al.  Inositol trisphosphate, a novel second messenger in cellular signal transduction , 1984, Nature.

[19]  Jurg Ott,et al.  Distribution and characterization of regulatory elements in the human genome. , 2002, Genome research.

[20]  T. Matsuishi,et al.  Prediction of resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease. , 2006, The Journal of pediatrics.

[21]  A. Marks,et al.  The Human Type 1 Inositol 1,4,5-Trisphosphate Receptor from T Lymphocytes , 1995, The Journal of Biological Chemistry.

[22]  D. Cooper,et al.  The mutational spectrum of single base-pair substitutions in mRNA splice junctions of human genes: Causes and consequences , 1992, Human Genetics.

[23]  M Farrall,et al.  Integrating case-control and TDT studies. , 2005, Annals of human genetics.

[24]  Seymour,et al.  Alternative splicing: a mechanism for phenotypic rescue of a common inherited defect. , 1993, The Journal of clinical investigation.

[25]  M. Oellerich,et al.  mRNA amount and expression in a stable reporter gene assay system efficiency and modulates effects of the 20210G>A polymorphism on The intronic prothrombin 19911A>G polymorphism influences splicing , 2010 .

[26]  R. Cantor,et al.  Family-based association analysis implicates IL-4 in susceptibility to Kawasaki disease , 2005, Genes and Immunity.

[27]  T. Kawasaki,et al.  [Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children]. , 1967, Arerugi = [Allergy].

[28]  L Timmermann,et al.  The mechanism of action of cyclosporin A and FK506. , 1996, Clinical immunology and immunopathology.

[29]  Yusuke Nakamura,et al.  A genomewide linkage analysis of Kawasaki disease: evidence for linkage to chromosome 12 , 2006, Journal of Human Genetics.

[30]  S. Berget,et al.  G triplets located throughout a class of small vertebrate introns enforce intron borders and regulate splice site selection , 1997, Molecular and cellular biology.

[31]  H Yanagawa,et al.  Kawasaki disease in parents and children , 2003, Acta paediatrica.

[32]  J. Newburger,et al.  Familial occurrence of Kawasaki syndrome in North America. , 2005, Archives of pediatrics & adolescent medicine.

[33]  F. Welch,et al.  Causes and Consequences , 2017, Nature.

[34]  H. Yanagawa,et al.  Kawasaki disease in families. , 1989, Pediatrics.

[35]  M. Farrall,et al.  Integrating Case‐control and TDT Studies , 2005 .

[36]  Gene W. Yeo,et al.  Variation in sequence and organization of splicing regulatory elements in vertebrate genes. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[37]  F. Macian,et al.  NFAT proteins: key regulators of T-cell development and function , 2005, Nature Reviews Immunology.

[38]  Y. Tsuruta,et al.  Polyclonal expansion of TCRBV2‐ and TCRBV6‐bearing T cells in patients with Kawasaki disease , 1999, Immunology.

[39]  Tomio Kobayashi,et al.  Prediction of Intravenous Immunoglobulin Unresponsiveness in Patients With Kawasaki Disease , 2006, Circulation.

[40]  Jurg Ott,et al.  Nucleotide frequency variation across human genes. , 2003, Genome research.